metyrapone and am 404
metyrapone has been researched along with am 404 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bitencourt, RM; Pamplona, FA; Takahashi, RN | 1 |
| Boos, FZ; Calcagnotto, ME; Crestani, AP; Lotz, FN; Quillfeldt, JA; Santana-Kragelund, F; Scienza-Martin, K; Zanona, QK | 1 |
Other Studies
2 other study(ies) available for metyrapone and am 404
| Article | Year |
|---|---|
Corticosteroid-endocannabinoid loop supports decrease of fear-conditioned response in rats.
Topics: Adrenal Cortex Hormones; Animals; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Modulators; Conditioning, Classical; Dexamethasone; Endocannabinoids; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; Male; Metyrapone; Mifepristone; Mineralocorticoid Receptor Antagonists; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Glucocorticoid; Rimonabant; Spironolactone | 2014 |
Memory Consolidation Depends on Endogenous Hippocampal Levels of Anandamide: CB1 and M4, but Possibly not TRPV1 Receptors Mediate AM404 effects.
Topics: Animals; Arachidonic Acids; Endocannabinoids; Hippocampus; Male; Memory Consolidation; Metyrapone; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Tropicamide | 2022 |